12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof
申请人:STERLING WINTHROP INC.
公开号:EP0648769A1
公开(公告)日:1995-04-19
12-Hetero substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.
An ultraviolet absorbent composition, having ultraviolet absorbent A and a silicon compound, in which the ultraviolet absorbent A has a maximum absorption wavelength from 350 nm to 400 nm, a half value width of 55 nm or less, and the molar extinction coefficient of 20000 or more at the maximum absorption wavelength.
Radiofluorinated compounds and their preparation
申请人:HAMMERSMITH IMANET LIMITED
公开号:US20140127130A1
公开(公告)日:2014-05-08
The present invention provides a process for [
18
F]-fluorination of biomolecules containing a primary amino group such as proteins and peptides and in particular of peptides. The invention further provides reagents for this process, in particular
18
F-labelled prosthetic groups for use in the preparation as well as non-labelled intermediates useful in the preparation of the [
18
F]-labelled prosthetic groups. [
18
F]-labelled compounds useful as radiopharmaceuticals, specifically for use in Positron Emission Tomography (PET) are also provided.